Skip Navigation

Company Profile

Name
Organogenesis Inc.
Descriptor

A leading tissue regeneration company with the unique skill set to take complex, living therapies from R&D, through manufacturing, to successful commercialization.

Mission

To bring the medical marvel of tissue regeneration to patients and to standardize its use in everyday medical care.

Founded

1985

Head Office
150 Dan Road
Canton, Massachusetts
02021
Google Map

General telephone number: (781)575-0775

Major Milestones
  • 1998: First FDA approval of a living, allogeneic, cell based product (Apligraf® approved for the treatment of venous leg ulcers.)
  • 2000: Apligraf® FDA approved for the treatment of diabetic foot ulcers.
  • 2004: Launch of full USA national sales and marketing organization.
  • 2005: Over 100,000 patients treated with a living, cell based therapy.

Employees

Over 200 employees in USA
2006 expansion to Switzerland

Areas of Focus
Three pillars:
  • Bio-active wound healing
  • Bio-aesthetics
  • Bio-surgery™
Key Pipeline Products

Multiple brands in active development in each of our three pillars of business.